Notably, the experiments reproduced previous observations of ~ 60% and 5% cancer cell survival (compared with unstimulated) after 24 h for the TRAIL and TR + BIS treatments, respectively (Fig. 2a–c, top panels). The gene discussed is TNFSF10; the disease is cancer.